Abstract:The extracellular matrix (ECM) is a critical component of tissue where it provides structural and signaling support to cells. Its dysregulation and accumulation lead to fibrosis, a major clinical challenge underlying many diseases that currently has little effective treatment. An understanding of the key molecular initiators of fibrosis would be both diagnostically useful and provide potential targets for therapeutics. The ECM protein fibronectin (FN) is upregulated in fibrotic conditions and other ECM proteins depend on assembly of a FN foundational ECM for their matrix incorporation. We used cell culture and in vivo models to investigate the role of FN in the progression of lung fibrosis. We confirmed that normal human lung fibroblasts (NHLFs) treated with transforming growth factor-beta (TGF-β) to stimulate fibrotic gene expression significantly increased both FN expression and its assembly into a matrix. We found that levels of alternatively spliced EDA and EDB exons were proportional to the increase in total FN RNA and protein showing that inclusion of these exons is not enhanced by TGF-β stimulation. RNA-sequencing identified 43 core matrisome genes that were significantly up- or down-regulated by TGF-β treatment and a Luminex immunoassay demonstrated increased levels of ECM proteins in conditioned medium of TGF-β-treated NHLFs. Interestingly, among the regulated core matrisome genes, 16 encode known FN-binding proteins and, of these, insulin-like growth factor binding protein 3 (IGFBP3) was most highly up-regulated. To link the NHLF results with in vivo disease, we analyzed lung tissue and bronchoalveolar lavage fluid from bleomycin-treated mice and found dramatically higher levels of FN and the FN-binding proteins IGFBP3, tenascin-C, and type I collagen in fibrotic conditions compared to controls. Altogether, our data identify a set of FN-binding proteins whose upregulation is characteristic of IPF and suggest that FN provides the foundational matrix for deposition of these proteins as fibrosis develops.

Epiregulin is a dendritic cell-derived EGFR ligand that maintains skin and lung fibrosis.

Role of endothelin-1 in the skin fibrosis of systemic sclerosis

Early Growth Response 3 (Egr-3) is Induced by Transforming Growth Factor-Β and Regulates Fibrogenic Responses.

Epidermal EGFR controls cutaneous host defense and prevents inflammation

Epiregulin, A Novel Egf Receptor Legend, Promotes Regeneration Of Renal Epithelial Cells

Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)

Essential Roles for Early Growth Response Transcription Factor Egr-1 in Tissue Fibrosis and Wound Healing

Epidermal growth factor receptor (EGFR) as a therapeutic target in rheumatoid arthritis

Identification of a fibronectin-binding protein signature associated with idiopathic pulmonary fibrosis

Smad-Independent Transforming Growth Factor-β Regulation of Early Growth Response-1 and Sustained Expression in Fibrosis

FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling

A fibroblast-dependent TGFβ1/sFRP2 noncanonical Wnt signaling axis underlies epithelial metaplasia in idiopathic pulmonary fibrosis

Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin

Epigenetics and Fibrosis

Epiregulin (EREG) and Myocardin Related Transcription Factor A (MRTF-A) Form a Feedforward Loop to Drive Hepatic Stellate Cell Activation

EphB2 receptor promotes dermal fibrosis in systemic sclerosis

Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cells.

Heparin-Binding Egf-Like Growth Factor Regulates Elastin and Fgf-2 Expression in Pulmonary Fibroblasts

A fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis

Endoglin Promotes TGF-β/Smad1 Signaling in Scleroderma Fibroblasts.

Identification of Ephrin type-B receptor 4 as a critical mediator of tissue fibrosis